Neoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell Carcinoma

Lance Cowey, C.; Amin, Chirag; S. Pruthi, Raj; Wallen, Eric; E. Nielsen, Matthew; Grigson, Gayle; Watkins, Cathy; V. Nance, Keith; M. Crane, Jeffrey; Jalkut, Mark; T. Moore, Dominic; Y. Kim, William; A. Godley, Paul; E. Whang, Young; R. Fielding, Julia; Kimryn Rathmell, W.

doi:10.1200/jco.2009.24.7759

Public

Neoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell Carcinoma

Published in Journal of Clinical Oncology • Feb 17, 2010

Authors:

C. Lance Cowey

Chirag Amin

Raj S. Pruthi

Abstract

PURPOSE: The multitargeted tyrosine kinase inhibitor sorafenib is used for the treatment of advanced-stage renal cell carcinoma. However, the safety and efficacy of this agent have yet to be evaluated in the preoperative period, where there may be potential advantages including tumor downstaging. Th...

Subject

Sorafenib

Medicine

Renal cell carcinoma

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!